Cipla to acquire Actor Pharma to dominate South African OTC market
In a strategic move that amplifies its commitment to the Over-The-Counter (OTC) business, Cipla South Africa, a 100% owned subsidiary of Cipla Limited (BSE: 500087; NSE: CIPLA EQ), has signed a binding term sheet to acquire Actor Pharma (Pty) Limited. This acquisition positions Cipla as a leading healthcare player in South Africa, targeting growth opportunities […]